The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 05, 2021

Filed:

Apr. 20, 2017
Applicants:

Oslo Universitetssykehus Hf, Oslo, NO;

Akershus Universitetssykehus Hf, Lørenskog, NO;

Inventors:

Kjell-Inge Gjesdal, Ålesund, NO;

Endre Grøvik, Oslo, NO;

Kathrine Røe Redalen, Fjerdingby, NO;

Tryggve Holck Storås, Oslo, NO;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06T 7/00 (2017.01); A61B 5/055 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
G06T 7/0014 (2013.01); A61B 5/055 (2013.01); A61B 5/418 (2013.01); A61B 5/7275 (2013.01); A61B 5/7485 (2013.01); A61B 2576/02 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/30096 (2013.01);
Abstract

Dynamic contrast enhanced MRI data and dynamic susceptibility contrast MRI data for a volume of the patient's body including a tumor are used in order to identify the risk of lymph node metastasis. A volume of interest enclosing the tumor is identified and the MRI data for the volume of interest is processed in order to identify one or more parameters relating to the transverse relaxation rate and/or to dynamic changes in the transverse relaxation rate. A comparison is made to previously obtained similar parameters for other patients having similar tumors that are either known to exhibit lymph node metastasis or are known not to exhibit lymph node metastasis in order to determine if the MRI data indicates that the patient has a tumor at greater risk of exhibiting lymph node metastasis or a tumor with a lesser risk of exhibiting lymph node metastasis.


Find Patent Forward Citations

Loading…